Valproate: Effective, and Restricted for a Reason
Valproate is a genuinely effective medicine. For several types of epilepsy it works better than anything else available, and it has controlled seizures in people for whom other drugs failed.
It also carries the highest risk to a developing baby of any medicine in routine use, and that fact governs everything about how it is prescribed. It belongs at the top of this article rather than buried in a list of side effects, because it is the single thing anyone taking it or considering it needs to know.
🔴 Valproate taken during pregnancy causes physical malformations in around one baby in ten — roughly four times the background rate — including defects of the spine, heart, face and limbs. And it causes lasting problems with learning and development in a substantially higher proportion, in the region of three or four in ten: reduced intellectual ability, a markedly increased likelihood of autism, and higher rates of attention difficulty. The risk is greater at higher doses and it is present at every dose.
This is not a theoretical concern from animal studies. It is measured in thousands of children, and it is the reason regulators across Europe and elsewhere have placed formal restrictions on its use that apply to no other epilepsy medicine.
If you are a woman able to become pregnant and you have been given valproate without a detailed conversation about this, raise it before your next dose. Not to stop it — stopping abruptly is dangerous — but because that conversation should have happened.
📋 The conditions attached to it
Because the risk is so specific, valproate is now supplied under formal requirements rather than ordinary prescribing.
For anyone able to become pregnant, that generally means it must not be used at all for migraine prevention or for bipolar disorder, where alternatives exist. For epilepsy it may be used where no other treatment controls the seizures, since uncontrolled seizures carry their own serious risks in pregnancy and outside it.
Where it is used, the requirements typically include highly effective contraception throughout, review by a specialist at least annually, and a signed acknowledgement confirming the risks have been explained and understood. Several countries have added a requirement for two specialists to agree before it is started in anyone under a certain age.
These are not bureaucratic formalities. They exist because for years the information did not reach the people taking the drug, and a generation of children was affected as a result.
⚠️ Newer guidance now covers men as well. A study raised the possibility that children fathered by men taking valproate in the months before conception may have a higher rate of neurodevelopmental problems. The evidence is limited and does not approach the certainty that exists for pregnancy exposure, and regulators have responded with a precaution rather than a prohibition: men taking valproate are advised to use effective contraception during treatment and for a period after stopping, and not to donate sperm. Anyone planning to father a child should raise it rather than assume the warnings apply only to women.
🎯 What it treats
Epilepsy is its principal use, and it is unusually broad — effective across generalised seizures including absence and myoclonic types, and against focal seizures. For some generalised epilepsies it remains the most effective option available, which is precisely why it has not simply been withdrawn.
Bipolar disorder, in mania and in longer-term prevention.
Migraine prevention, where attacks are frequent enough to justify daily treatment.
The distinction between these matters enormously in practice. For migraine and for bipolar disorder, alternatives exist that do not carry this risk. For certain epilepsies, sometimes they do not — and that difference is why the restrictions are absolute in the first two situations and conditional in the third.
⚡ How it works
Valproate acts through several mechanisms at once, which is the likely explanation for its unusually broad effectiveness.
It raises levels of the brain’s main calming signal, dampens the sodium channels that carry rapid nerve firing, and affects a particular calcium channel involved in the rhythm underlying absence seizures. No other antiepileptic covers quite the same range.
The names cause confusion and refer to essentially the same thing: sodium valproate, valproic acid, valproate semisodium and divalproex are different salts and formulations of the same active substance. Switching between preparations is not automatic, since absorption differs.
💊 Taking it
With or after food, which reduces stomach upset.
Swallowed whole where the preparation is modified-release — crushing or chewing one of those releases the whole dose at once.
Consistently, at the same times, since fluctuating levels are what allow seizures through.
Built up gradually at the start, which reduces nausea and drowsiness.
Not stopped abruptly. In epilepsy, sudden withdrawal can precipitate prolonged seizures that are themselves life-threatening. Any reduction is planned and gradual.
📉 What it does to people taking it
Beyond the pregnancy risk, the everyday effects are what determine whether people stay on it.
- Weight gain
- Common and frequently substantial, through increased appetite. It is one of the main reasons people stop, and it deserves discussing at the outset rather than being discovered.
- Hair thinning or loss
- Occurs in a minority, is usually temporary, and hair typically regrows — sometimes curlier or a different texture than before.
- Tremor
- A fine shake of the hands, dose-related, and often improved by reducing the dose slightly.
- Drowsiness and slowed thinking
- Usually settling after the first weeks.
- Nausea and stomach upset
- Common early, reduced by taking it with food.
- Menstrual irregularity
- Valproate is associated with disturbed cycles and with features of polycystic ovary syndrome, more so when started in adolescence.
🚨 The rare and serious
Three complications are uncommon and require recognition, because early action changes the outcome.
🔴 Liver failure. Rare, and it can be fatal. Risk is highest in very young children, in anyone with an inherited disorder of cellular energy production, and usually within the first six months of treatment. The warning signs are not jaundice initially — they are repeated vomiting, unusual tiredness and weakness, loss of appetite, swelling, and a sudden loss of seizure control in someone previously stable. That last one is easily read as the epilepsy worsening. Any of these means stopping and being assessed the same day.
Pancreatitis. Also rare, also potentially fatal, and it can occur at any point rather than only early. Severe upper abdominal pain boring through to the back, with vomiting, needs emergency assessment.
Raised ammonia. Valproate can cause ammonia to accumulate, producing confusion, lethargy and vomiting — and it can do so while liver blood tests remain entirely normal, which is why it gets missed. Unexplained confusion or drowsiness in someone taking valproate should prompt an ammonia level specifically.
🔬 What is monitored
Liver function and a full blood count before starting and periodically afterwards, most closely in the first six months.
Platelets, since valproate lowers them and also affects how well they work, which matters before surgery or dental extraction.
Weight, deliberately rather than incidentally.
Blood levels are not routinely needed to judge whether the dose is right — that is judged by seizure control — but they help where adherence is uncertain, where toxicity is suspected, or in pregnancy where levels shift.
🔗 Interactions worth knowing
Two matter more than the rest.
Lamotrigine. Valproate roughly doubles lamotrigine levels, so when the two are combined the lamotrigine dose is halved and increased even more slowly than usual. Getting this wrong raises the risk of the serious skin reaction that lamotrigine can cause. It applies in both directions — starting or stopping either drug requires the other to be reviewed.
Certain intravenous antibiotics of the carbapenem group, used in hospital for serious infections, cause valproate levels to collapse within a day or two, frequently to undetectable. Seizures break through in someone who has been stable for years, and the cause is regularly not identified. Anyone with epilepsy admitted to hospital and started on an intravenous antibiotic should have this considered.
Beyond those: aspirin raises the active fraction of valproate; carbamazepine, phenytoin and phenobarbital lower its levels; and valproate raises phenobarbital levels. Alcohol adds to the drowsiness.
🔄 The alternatives
Whether an alternative exists depends entirely on what is being treated, which is the crux of the whole restriction.
| Condition | Alternatives without this risk |
|---|---|
| Migraine prevention | Several, including beta blockers, low-dose amitriptyline, flunarizine and newer targeted treatments. Valproate should not be used here in anyone who could become pregnant |
| Bipolar disorder | Lithium, lamotrigine and several antipsychotics. Same conclusion |
| Focal epilepsy | Levetiracetam, lamotrigine, oxcarbazepine, carbamazepine and others |
| Generalised epilepsy | Levetiracetam and lamotrigine are the main options, and for some people they genuinely do not work as well. This is the situation the restrictions were written for |
One caution on alternatives: topiramate, frequently used for both migraine and epilepsy, carries its own risk in pregnancy and has recently attracted restrictions of its own. Swapping one for the other without checking is not a solution.
🤰 If pregnancy occurs
Do not stop valproate suddenly. An uncontrolled seizure is dangerous to both mother and pregnancy, and abrupt withdrawal is a recognised cause of one. The correct action is urgent contact with the prescriber — the same day — rather than a decision made alone.
What follows is a specialist discussion about whether the dose can be reduced, whether a switch is possible at that stage, high-dose folic acid, additional scanning, and delivery planning. None of it is improved by the drug having been stopped in panic first.
Anyone taking valproate who is planning a pregnancy should have that conversation before conceiving, since the highest-risk period for malformation is the first weeks — often before a pregnancy is even confirmed.
🩺 When to seek help
- Repeated vomiting, unusual weakness, loss of appetite or swelling — possible liver injury, same day
- Severe abdominal pain going through to the back — emergency
- New confusion or drowsiness — ask for an ammonia level, not only liver tests
- A sudden loss of seizure control in someone previously stable
- Any rash, particularly if lamotrigine has been started or increased alongside
- Unusual bruising or bleeding
- Yellowing of the skin or eyes
- A positive pregnancy test —> contact the prescriber the same day, and do not stop the drug yourself
- Planning a pregnancy, or fathering a child — before, not after
- Admission to hospital with an infection — make sure the epilepsy medication is flagged
Depakote (divalproex) is stocked in the migraine category, and alternatives without this risk are stocked in the anticonvulsant category — including Keppra (levetiracetam) and Lamictal (lamotrigine). This is not a medicine to start, switch or stop without a prescriber, and for anyone able to become pregnant it should not be started for migraine or bipolar disorder at all.
❓ Frequently asked questions
What exactly is the risk in pregnancy?
Physical malformations in around one baby in ten exposed, roughly four times the background rate, affecting the spine, heart, face and limbs. And lasting problems with learning and development in a substantially higher proportion, in the region of three or four in ten — reduced intellectual ability, a markedly increased likelihood of autism, and higher rates of attention difficulty. Greater at higher doses, present at every dose.
Why is it still available if the risk is that high?
Because for some types of epilepsy it works better than anything else, and uncontrolled seizures carry serious risks of their own including death. That is why the restrictions differ by condition: for migraine prevention and bipolar disorder, where alternatives exist, it should not be used in anyone able to become pregnant. For certain epilepsies it may be, where nothing else controls the seizures.
Nobody discussed this with me. What should I do?
Raise it before your next dose — but do not stop the drug yourself, because abrupt withdrawal in epilepsy can cause prolonged and dangerous seizures. The conversation should have included the specific risks, effective contraception, annual specialist review and a signed acknowledgement. Its absence is a gap in your care rather than a reason to act alone.
Do the warnings apply to men?
Newer guidance does cover men, at a lower level of certainty. A study raised the possibility that children fathered by men taking valproate in the months before conception may have higher rates of neurodevelopmental problems. Regulators responded with a precaution rather than a prohibition: effective contraception during treatment and for a period after, and no sperm donation. Raise it if you are planning to father a child.
What are the early signs of liver problems?
Not jaundice, initially. Repeated vomiting, unusual tiredness and weakness, loss of appetite, swelling — and a sudden loss of seizure control in someone previously stable, which is easily misread as the epilepsy worsening. Risk is highest in very young children and within the first six months. Any of these means stopping and being assessed the same day.
Why would confusion matter?
Because valproate can cause ammonia to accumulate, producing confusion, lethargy and vomiting — and it can do so while liver blood tests remain entirely normal, which is why it gets missed. Unexplained confusion or drowsiness in someone taking valproate should prompt an ammonia level specifically, rather than reassurance that the liver tests are fine.
Why does the lamotrigine dose change?
Because valproate roughly doubles lamotrigine levels. When the two are combined the lamotrigine dose is halved and increased even more slowly than usual, since getting it wrong raises the risk of the serious skin reaction lamotrigine can cause. It works in both directions, so starting or stopping either drug means reviewing the other.
Can an antibiotic affect my seizures?
One group can, dramatically. Certain intravenous antibiotics used in hospital for serious infections cause valproate levels to collapse within a day or two, frequently to undetectable, and seizures break through in someone stable for years. The cause is regularly not identified. Anyone with epilepsy admitted to hospital and started on an intravenous antibiotic should have their epilepsy medication flagged explicitly.
I am pregnant and taking it. What now?
Contact the prescriber the same day and do not stop the drug yourself — an uncontrolled seizure is dangerous to both mother and pregnancy, and abrupt withdrawal is a recognised cause of one. What follows is a specialist discussion about dose, whether a switch is possible at that stage, high-dose folic acid, additional scanning and delivery planning. None of that is improved by stopping in panic first.
Is there a safer alternative?
It depends entirely on what is being treated. For migraine prevention and bipolar disorder, yes — several, which is precisely why valproate should not be used for those in anyone able to become pregnant. For focal epilepsy, several. For some generalised epilepsies the alternatives genuinely do not work as well, which is the situation the restrictions were written for. Note that topiramate carries its own pregnancy risk.
📑 Sources and editorial
- European Medicines Agency and national regulator reviews of valproate in pregnancy, and resulting restrictions
- Pregnancy Prevention Programme requirements for valproate
- Registry data on major congenital malformation rates with antiepileptic drug exposure
- Cohort studies of neurodevelopmental outcomes following in-utero valproate exposure
- Regulatory communications on possible risk associated with paternal valproate exposure
- Prescribing information for valproate, including hepatic and pancreatic warnings
- Literature on valproate-induced hyperammonaemic encephalopathy with normal liver enzymes
- Pharmacokinetic studies of the valproate and lamotrigine interaction
- Reports of carbapenem-induced reduction in valproate concentrations
- Comparative efficacy trials of valproate, levetiracetam and lamotrigine in generalised epilepsy
- Related reading: bipolar disorder, migraine treatment, psychiatric drug classes
- Related products: anticonvulsant category
- RXshop Editorial Team — reviewed by James Carter, MD, Neurologist
Medical Disclaimer: The information in this article is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek guidance from a qualified healthcare provider with any questions you may have regarding a medical condition, and before starting, stopping or changing any medication.